Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 HLA-B*51 the primary risk in Behçet disease.

Literature DB >> 24876276

HLA-B*51 the primary risk in Behçet disease.

Graham R Wallace¹.

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 2014 PMID： 24876276 PMCID： PMC4066492 DOI： 10.1073/pnas.1407307111

Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN： 0027-8424 Impact factor: 11.205

× No keyword cloud information.

18 in total

1. Localization of the pathogenic gene of Behçet's disease by microsatellite analysis of three different populations.

Authors: N Mizuki; M Ota; K Yabuki; Y Katsuyama; H Ando; G D Palimeris; E Kaklamani; M Accorinti; P Pivetti-Pezzi; S Ohno; H Inoko
Journal: Invest Ophthalmol Vis Sci Date: 2000-11 Impact factor: 4.799

Review 2. Behçet's disease: from Hippocrates to the third millennium.

Authors: D H Verity; G R Wallace; R W Vaughan; M R Stanford
Journal: Br J Ophthalmol Date: 2003-09 Impact factor: 4.638

3. An NKG2D-mediated human lymphoid stress surveillance response with high interindividual variation.

Authors: Seema Shafi; Pierre Vantourout; Graham Wallace; Ayman Antoun; Robert Vaughan; Miles Stanford; Adrian Hayday
Journal: Sci Transl Med Date: 2011-11-30 Impact factor: 17.956

4. Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci.

Authors: Nobuhisa Mizuki; Akira Meguro; Masao Ota; Shigeaki Ohno; Tomoko Shiota; Tatsukata Kawagoe; Norihiko Ito; Jiro Kera; Eiichi Okada; Keisuke Yatsu; Yeong-Wook Song; Eun-Bong Lee; Nobuyoshi Kitaichi; Kenichi Namba; Yukihiro Horie; Mitsuhiro Takeno; Sunao Sugita; Manabu Mochizuki; Seiamak Bahram; Yoshiaki Ishigatsubo; Hidetoshi Inoko
Journal: Nat Genet Date: 2010-07-11 Impact factor: 38.330

5. Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behçet disease.

Authors: N Mizuki; M Ota; M Kimura; S Ohno; H Ando; Y Katsuyama; M Yamazaki; K Watanabe; K Goto; S Nakamura; S Bahram; H Inoko
Journal: Proc Natl Acad Sci U S A Date: 1997-02-18 Impact factor: 11.205

6. Close association of HLA-Bw51 with Behçet's disease.

Authors: S Ohno; M Ohguchi; S Hirose; H Matsuda; A Wakisaka; M Aizawa
Journal: Arch Ophthalmol Date: 1982-09

7. MIC-A allele profiles and HLA class I associations in Behçet's disease.

Authors: G R Wallace; D H Verity; L J Delamaine; S Ohno; H Inoko; M Ota; N Mizuki; K Yabuki; E Kondiatis; H A Stephens; W Madanat; C A Kanawati; M R Stanford; R W Vaughan
Journal: Immunogenetics Date: 1999-07 Impact factor: 2.846

8. Combination of KIR and HLA gene variants augments the risk of developing birdshot chorioretinopathy in HLA-A*29-positive individuals.

Authors: R D Levinson; Z Du; L Luo; D Monnet; T Tabary; A P Brezin; L Zhao; D W Gjertson; G N Holland; E F Reed; J H M Cohen; R Rajalingam
Journal: Genes Immun Date: 2008-03-13 Impact factor: 2.676

Review 9. The Yin and Yang of HLA and KIR in human disease.

Authors: Smita Kulkarni; Maureen P Martin; Mary Carrington
Journal: Semin Immunol Date: 2008-07-16 Impact factor: 11.130

10. In vivo role of ER-associated peptidase activity in tailoring peptides for presentation by MHC class Ia and class Ib molecules.

Authors: Jingbo Yan; Vrajesh V Parekh; Yanice Mendez-Fernandez; Danyvid Olivares-Villagómez; Srdjan Dragovic; Timothy Hill; Derry C Roopenian; Sebastian Joyce; Luc Van Kaer
Journal: J Exp Med Date: 2006-02-27 Impact factor: 14.307

16 in total

Review 1. Epidemiology and management of neuropsychiatric disorders in Behçet's syndrome.

Authors: Rosaria Talarico; Laura Palagini; Anna d'Ascanio; Elena Elefante; Claudia Ferrari; Chiara Stagnaro; Chiara Tani; Angelo Gemignani; Mauro Mauri; Stefano Bombardieri; Marta Mosca
Journal: CNS Drugs Date: 2015-03 Impact factor: 5.749

2. HLA class I variation in Iranian Lur and Kurd populations: high haplotype and allotype diversity with an abundance of KIR ligands.

Authors: E Ashouri; P J Norman; L A Guethlein; A S Han; N Nemat-Gorgani; S J Norberg; A Ghaderi; P Parham
Journal: HLA Date: 2016-08-24 Impact factor: 4.513

Review 3. The Immunogenetics of Vasculitis.

Authors: Fotini B Karassa; Eleftherios Pelechas; Georgios Zouzos
Journal: Adv Exp Med Biol Date: 2022 Impact factor: 2.622

4. Behçet's disease risk-variant HLA-B51/ERAP1-Hap10 alters human CD8 T cell immunity.

Authors: Ann Cavers; Matthias Christian Kugler; Yesim Ozguler; Arshed Fahad Al-Obeidi; Gulen Hatemi; Beatrix M Ueberheide; Didar Ucar; Olivier Manches; Johannes Nowatzky
Journal: Ann Rheum Dis Date: 2022-08-03 Impact factor: 27.973

5. Post-translational modifications reshape the antigenic landscape of the MHC I immunopeptidome in tumors.

Authors: Assaf Kacen; Aaron Javitt; Matthias P Kramer; David Morgenstern; Tomer Tsaban; Merav D Shmueli; Guo Ci Teo; Felipe da Veiga Leprevost; Eilon Barnea; Fengchao Yu; Arie Admon; Lea Eisenbach; Yardena Samuels; Ora Schueler-Furman; Yishai Levin; Alexey I Nesvizhskii; Yifat Merbl
Journal: Nat Biotechnol Date: 2022-10-06 Impact factor: 68.164